AREV's a life science development enterprise focused on phytomedicinal extraction of novel therapeutic approaches to infectious diseases and subsequent comorbidities via our proprietary extraction systems to identify promising small molecules that present novel mechanisms of action in human and veterinary science.
AREV Nanotec initiates early-stage antiviral photochemistry derivation
discovery program for pandemic viral pathogens
AREV Nanotechnology becomes a sponsor of the National Sciences Acedemy 2021 Hemp Symposium
AREV APPOINTS THE FORMER,
ASSISTANT U.S SURGEON GENERAL,
DR. ROSCOE MOORE TO JOIN ADVISORY BOARD